LI-RADS v2017 应用 CT 对肝细胞癌分类:中重度脂肪肝是否影响准确性
该回顾性研究纳入 106 例高危患者的 112 个病理证实肝细胞癌,比较多期 CT 上 LI-RADS v2017 在中重度脂肪肝与非中重度脂肪肝患者中诊断肝细胞癌的敏感度。两位阅片者 LR-5 类诊断敏感度在中重度脂肪肝组与非中重度脂肪肝组间无显著差异,主要 HCC 征象频率亦无显著差异。结论认为 LI-RADS v2017 应用 CT 诊断 HCC 的敏感度在中重度脂肪肝患者中与非中重度脂肪肝患者相当。
要点
- 中重度脂肪肝组与非中重度脂肪肝组 LR-5 类诊断 HCC 的敏感度无显著差异。
- 两组间动脉期明显强化、廓清和包膜等主要 HCC 征象的频率无显著差异。
- LI-RADS v2017 应用 CT 在中重度脂肪肝患者中诊断 HCC 的敏感度与非中重度脂肪肝患者相当。
核心结论
- LI-RADS v2017 应用 CT 诊断 HCC 的敏感度在中重度脂肪肝患者与非中重度脂肪肝患者中相当。
研究设计与样本
- 回顾性研究,纳入 106 例高危患者共 112 个病理证实的 HCC,均接受多期 CT 检查;根据平扫 CT 肝脾实质衰减分为中重度脂肪肝组(24 男、2 女,平均年龄 59.5 岁,范围 38-79 岁)和非中重度脂肪肝组(64 男、16 女,平均年龄 62.9 岁,范围 40-89 岁);由两位独立放射科医师盲法(原文未写明盲法,此处删除)分配 LI-RADS 类别并评估 HCC 征象。
关键影像表现/征象
- 中重度脂肪肝组动脉期明显强化频率 96.2%(25/26),非中重度脂肪肝组 98.8%(85/86),两组无显著差异(p=0.412)。
- 中重度脂肪肝组廓清频率 80.8%(21/26),非中重度脂肪肝组 89.5%(77/86),两组无显著差异(p=0.308)。
- 中重度脂肪肝组包膜频率 53.8%(14/26),非中重度脂肪肝组 57%(49/86),两组无显著差异(p=0.778)。
诊断标准与关键数值
- 阅片者 1 的 LR-5 类诊断 HCC 敏感度:中重度脂肪肝组 65.4%(17/26) vs 非中重度脂肪肝组 76.7%(66/86),p=0.247。
- 阅片者 2 的 LR-5 类诊断 HCC 敏感度:中重度脂肪肝组 73.1%(19/26) vs 非中重度脂肪肝组 76.74%(66/86),p=0.702。
- 中重度脂肪肝与非中重度脂肪肝的判定依据为平扫 CT 肝脾实质衰减,原文未报告具体阈值。
临床应用与阅片要点
- 应用 LI-RADS v2017 在多期 CT 上评估 HCC 时,中重度脂肪肝患者与非中重度脂肪肝患者的 LR-5 类诊断敏感度无显著差异。
- 中重度脂肪肝患者中动脉期明显强化、廓清和包膜征象的出现频率与非中重度脂肪肝患者无显著差异。
- 原文结论认为 LI-RADS 应用 CT 在中重度脂肪肝患者中诊断 HCC 可能是可行的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare the sensitivity of Liver Imaging Reporting and Data System (LI-RADS) v2017 for diagnosis of hepatocellular carcinoma (HCC) using multiphasic computed tomography (CT) between patients with and without moderate to severe fatty liver (MSFL).
METHODS: This retrospective study included a total of 106 high-risk patients with 112 pathologically proven HCCs who underwent multiphasic CT. Patients were classified as MSFL (24 men, 2 women; mean age, 59.5 years [range, 38-79 years]) and non-MSFL (64 men, 16 women; mean age, 62.9 years [range, 40-89 years]) groups according to unenhanced CT liver and spleen parenchymal attenuation. Two independent radiologists assigned LI-RADS categories and accessed HCC features on CT. Sensitivities for LR-5 assignment and frequencies of HCC features were compared between the two groups.
RESULTS: Sensitivities of LR-5 assignment for diagnosing HCCs were not significantly different between MSFL and non-MSFL groups (65.4% [17/26] vs. 76.7% [66/86] for reviewer 1, p = 0.247; 73.1% [19/26] vs. 76.74% [66/86] for reviewer 2, p = 0.702). No significant differences in the frequencies of arterial hyperenhancement, washout, and capsule were observed between the two groups (96.2% [25/26] vs. 98.8% [85/86], p = 0.412; 80.8% [21/26] vs. 89.5% [77/86], p = 0.308; and 53.8% [14/26] vs. 57% [49/86], p = 0.778, respectively).
CONCLUSIONS: LI-RADS v2017 using CT showed comparable sensitivity for diagnosing HCC regardless of MSFL.
KEY POINTS: • Using LI-RADS v2017 with CT, diagnosis of HCC in patients with MSFL showed similar sensitivity to that in patients without MSFL. • Frequencies of major HCC features (arterial hyperenhancement, washout, and capsule) on CT between the MSFL and non-MSFL groups were not significantly different. • LI-RADS using CT may be feasible for diagnosing HCC in patients with fatty liver.
引用
- Kim SS, Hwang JA, Shin HC, et al. LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy? Eur Radiol. 2018. PMID: 30073499. doi:10.1007/s00330-018-5657-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。